Abstract
Background and Goals: The current study investigated the relationship between gang involvement and multiple mental health difficulties; anxiety, depression, paranoia, victim trauma and perpetrator trauma. Additionally, it examined the mediating influence of an individual’s exposure to violence within this relationship.
Method: One hundred adolescents aged 11-16 years old completed two questionnaires and an interview which investigated their friendship groups, exposure to violence and mental well-being. Eighteen participants were identified as current or ex-gang members and the other eighty-two were classified as the nongang comparison group. Results: Findings show that gang members displayed more symptoms of depression and perpetrator trauma compared to non-gang members. The relationship between gang involvement and these mental health difficulties was mediated by exposure to violence. Conclusion: Discussion focuses on the need for researchers, practitioners and policymakers to acknowledge the relationship between gang involvement and mental health difficulties and implement additional strategies to support young people currently or previously involved in gangs.Keywords: Gangs, anxiety, depression, paranoia, victim and perpetrator trauma, mental-illness.
Adolescent Psychiatry
Title:Gang Involvement, Mental Health Difficulties and Exposure to Violence in 11-16-Year-Old School Students
Volume: 10 Issue: 4
Author(s): Georgia A. Naldrett and Jane L Wood*
Affiliation:
- Centre of Research and Education in Forensic Psychology (CORE-FP), School of Psychology, University of Kent, Canterbury, Kent, CT2 7NP,United Kingdom
Keywords: Gangs, anxiety, depression, paranoia, victim and perpetrator trauma, mental-illness.
Abstract: Background and Goals: The current study investigated the relationship between gang involvement and multiple mental health difficulties; anxiety, depression, paranoia, victim trauma and perpetrator trauma. Additionally, it examined the mediating influence of an individual’s exposure to violence within this relationship.
Method: One hundred adolescents aged 11-16 years old completed two questionnaires and an interview which investigated their friendship groups, exposure to violence and mental well-being. Eighteen participants were identified as current or ex-gang members and the other eighty-two were classified as the nongang comparison group. Results: Findings show that gang members displayed more symptoms of depression and perpetrator trauma compared to non-gang members. The relationship between gang involvement and these mental health difficulties was mediated by exposure to violence. Conclusion: Discussion focuses on the need for researchers, practitioners and policymakers to acknowledge the relationship between gang involvement and mental health difficulties and implement additional strategies to support young people currently or previously involved in gangs.Export Options
About this article
Cite this article as:
Naldrett A. Georgia and Wood L Jane *, Gang Involvement, Mental Health Difficulties and Exposure to Violence in 11-16-Year-Old School Students, Adolescent Psychiatry 2020; 10 (4) . https://dx.doi.org/10.2174/2210676610999201229141153
DOI https://dx.doi.org/10.2174/2210676610999201229141153 |
Print ISSN 2210-6766 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-6774 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Is α7-nAChR a Possible Target for Lung Cancer and Malignant Pleural Mesothelioma Treatment?
Current Drug Targets A Role for Calcineurin in Alzheimers Disease
Current Neuropharmacology Leptin, Immune Responses and Autoimmune Disease. Perspectives on the Use of Leptin Antagonists
Current Pharmaceutical Design Steroids and the Immune Response in Graves Orbitopathy
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Sirtuins: Common Targets in Aging and in Neurodegeneration
Current Drug Targets ABC Transporters: Regulation and Association with Multidrug Resistance in Hepatocellular Carcinoma and Colorectal Carcinoma
Current Medicinal Chemistry Peptide-based Vaccines in the Treatment of Specific Allergy
Current Drug Targets - Inflammation & Allergy STABIL-study: The Course of Therapy, Safety and Pharmacokinetic Parameters of Conversion of Prograf® to Tacrolimus HEXAL®/Crilomus® in Renal Transplant Recipients – an Observational Study in Germany
Current Reviews in Clinical and Experimental Pharmacology From Small to Big Molecules: How Do We Prevent and Delay the Progression of Age-Related Neurodegeneration?
Current Pharmaceutical Design Need for Nutritious Convenience Foods for the Elderly Population: A Review
Current Nutrition & Food Science The Potential Dual Effects of Anesthetic Isoflurane on Aβ-Induced Apoptosis
Current Alzheimer Research Globalization of Clinical Trials – Where are We Heading?
Current Clinical Pharmacology Age-Related Mitochondrial Alterations without Neuronal Loss in the Hippocampus of a Transgenic Model of Alzheimer's Disease
Current Alzheimer Research Abnormal Sleep Behaviours Across the Spectrum of Alzheimer’s Disease Severity: Influence of APOE Genotypes and Lewy Bodies
Current Alzheimer Research Assessment and Imaging of the Cerebrovascular Glycocalyx
Current Neurovascular Research Mesenchymal Stem Cells: New Approaches for the Treatment of Neurological Diseases
Current Stem Cell Research & Therapy Naturalistic Measurement of Sleep in Older Adults with Amnestic Mild Cognitive Impairment: Anxiety Symptoms Do Not Explain Sleep Disturbance
Current Alzheimer Research Current Treatments of Muco-Cutaneous Herpes Simplex Virus Infections
Current Medicinal Chemistry - Anti-Infective Agents FTD and ALS: A Tale of Two Diseases
Current Alzheimer Research Migraine in Systemic Autoimmune Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets